Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131812) titled 'A Clinical Study of Mitochondrial Genome Mutations in Postoperative Recurrence Monitoring of Urothelial Carcinoma' on Sept. 7.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai General Hospital
Condition:
Urothelial Carcinoma
Intervention:
Gold Standard:Cystoscopy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-12-29
Target Sample Size: Target condition:30;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311065
Published by HT Digital Content Services wit...